Diluted EPS came in at $-0.64 (-146.2% YoY).
Trailing eight quarters through Q1 2026
Common questions about Genprex's Q1 2026 earnings report.
Genprex (GNPX) reported Q1 2026 earnings on May 13, 2026 after market close.
Genprex reported diluted EPS of $-0.64 for Q1 2026.
Compared to the same quarter a year prior, diluted EPS declined 146.2% from $-0.26.
You can read the 8-K earnings release (0001437749-26-016883) and the 10-Q periodic report (0001437749-26-016755) directly on SEC EDGAR. The filing index links above go to sec.gov.